6547 高端疫苗本益比(PER)
| 年度/月份 | 本益比(倍) | 月收盤價 |
|---|
| 2026/05 | -112.44 | 48.35 |
| 2026/04 | -114.77 | 49.35 |
| 2026/03 | -133.26 | 57.30 |
| 2026/02 | -82.56 | 35.50 |
| 2026/01 | -87.33 | 37.55 |
| 2025/12 | -87.79 | 37.75 |
| 2025/11 | -97.67 | 42.00 |
| 2025/10 | -82.09 | 35.30 |
| 2025/09 | -90.12 | 38.75 |
| 2025/08 | -90.35 | 38.85 |
| 2025/07 | -539.38 | 43.15 |
| 2025/06 | -525.63 | 42.05 |
| 2025/05 | -645.00 | 51.60 |
| 2025/04 | -229.58 | 55.10 |
| 2025/03 | -201.04 | 48.25 |
| 2025/02 | -204.58 | 49.10 |
| 2025/01 | -25.15 | 49.05 |
| 2024/12 | -18.49 | 36.05 |
| 2024/11 | -20.15 | 39.30 |
| 2024/10 | -19.67 | 41.50 |
| 2024/09 | -21.42 | 45.20 |
| 2024/08 | -23.51 | 49.60 |
| 2024/07 | -15.08 | 46.75 |
| 2024/06 | -17.74 | 55.00 |
| 2024/05 | -16.81 | 52.10 |
| 2024/04 | -14.62 | 51.60 |
| 2024/03 | -14.73 | 52.00 |
| 2024/02 | -17.34 | 61.20 |
| 2024/01 | -15.16 | 60.20 |
| 2023/12 | -17.66 | 70.10 |
| 2023/11 | -18.11 | 71.90 |
| 2023/10 | -17.14 | 69.60 |
| 2023/09 | -17.93 | 72.80 |
| 2023/08 | -18.79 | 76.30 |
| 2023/07 | -12.53 | 57.00 |
| 2023/06 | -13.54 | 61.60 |
| 2023/05 | -13.63 | 62.00 |
| 2023/04 | -14.45 | 65.90 |
| 2023/03 | -12.70 | 57.90 |
| 2023/02 | -13.53 | 61.70 |
| 2023/01 | 27.49 | 73.40 |
| 2022/12 | 26.03 | 69.50 |
| 2022/11 | 30.34 | 81.00 |
| 2022/10 | 10.49 | 64.40 |
| 2022/09 | 12.98 | 79.70 |
| 2022/08 | 23.94 | 147.00 |
| 2022/07 | 30.61 | 206.00 |
| 2022/06 | 30.46 | 205.00 |
| 2022/05 | 33.21 | 223.50 |
| 2022/04 | 37.67 | 250.50 |
| 2022/03 | 40.15 | 267.00 |
| 2022/02 | 35.11 | 233.50 |
| 2022/01 | 372.79 | 253.50 |
| 2021/12 | 439.71 | 299.00 |
| 2021/11 | 354.41 | 241.00 |
| 2021/10 | -68.18 | 240.00 |
| 2021/09 | -77.70 | 273.50 |
| 2021/08 | -85.94 | 302.50 |
| 2021/07 | -77.08 | 277.50 |
| 2021/06 | -68.61 | 247.00 |
| 2021/05 | -97.36 | 350.50 |
| 2021/04 | -78.95 | 285.00 |
| 2021/03 | -80.06 | 289.00 |
| 2021/02 | -48.61 | 175.50 |
| 2021/01 | - | 103.00 |